Logo
x

Search

Subscribe Now

 Pharma

PharmaShots Weekly Snapshots (March 31, 2025 – April 04, 2025)

PharmaShots Weekly Snapshots (March 31, 2025 – April 04, 2025)

  • April 4, 2025
Reuters Pharma 2025: Pre-Conference Talks Featuring Konrad Dobschuetz

Reuters Pharma 2025: Pre-Conference Talks Featuring Konrad Dobschuetz

  • April 4, 2025
Eli Lilly Enters a ~$1.4B Licensing Agreement with Sangamo Therapeutics for its STAC-BBB Capsid

Eli Lilly Enters a ~$1.4B Licensing Agreement with Sangamo Therapeutics for its STAC-BBB Capsid

  • April 4, 2025
Sanofi Licenses an Undisclosed Nurix Therapeutics’ Drug Program for Autoimmune Diseases

Sanofi Licenses an Undisclosed Nurix Therapeutics’ Drug Program for Autoimmune Diseases

  • April 3, 2025
Reuters Pharma 2025: Pre-Conference Talks Featuring Vikram Mohan

Reuters Pharma 2025: Pre-Conference Talks Featuring Vikram Mohan

  • April 2, 2025
Ono Enters into an Option Agreement with Reborna Biosciences for RNA-Targeting Small Molecule to treat CNS Disorders

Ono Enters into an Option Agreement with Reborna Biosciences for RNA-Targeting Small Molecule to treat CNS Disorders

  • April 1, 2025
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.